Eupraxia Pharmaceuticals Inc. (EPRX) Financials

$3.65

north_east
$0.1 (2.71%)
Day's range
$3.53
Day's range
$3.75
$0$0-$10M-$10M-$20M-$20M-$30M-$30M-$40M-$40MEarning201720172018201820192019202020202021202120222022202320234%4%3%3%2%2%1%1%0%0%Profit Margin
Profit Margin
Revenue
Earnings

EPRX Income statement / Annual

Last year (2023), Eupraxia Pharmaceuticals Inc.'s total revenue was $0.00, and the percentage change from the previous year is not available. In 2023, Eupraxia Pharmaceuticals Inc.'s net income was -$37.39 M. See Eupraxia Pharmaceuticals Inc.,s key income statements, including revenue, expenses, profit, and income.

Period FY-2023 FY-2022 FY-2021 FY-2020 FY-2019 FY-2018 FY-2017
Period Ended 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017
Operating Revenue $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Cost of Revenue $209,911.00 $193,273.00 $111,529.00 $116,809.00 $201,936.00 $125,826.00 $85,376.00
Gross Profit -$209,911.00 -$193,273.00 -$111,529.00 -$116,809.00 -$201,936.00 -$125,826.00 -$85,376.00
Gross Profit Ratio 0 0 0 0 0 0 0
Research and Development Expenses $27.54 M $17.20 M $9.68 M $859,781.00 $2.94 M $6.64 M $3.19 M
General & Administrative Expenses $9.65 M $5.81 M $8.89 M $1.27 M $3.01 M $7.54 M $1.70 M
Selling & Marketing Expenses $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Selling, General & Administrative Expenses $9.65 M $5.81 M $8.89 M $1.27 M $3.01 M $7.54 M $1.70 M
Other Expenses $0.00 $0.00 -$2.26 M $0.00 $1,737.00 $0.00 $0.00
Operating Expenses $37.92 M $23.20 M $18.68 M $2.25 M $6.16 M $14.31 M $4.97 M
Cost And Expenses $37.92 M $23.20 M $18.68 M $2.25 M $6.16 M $14.31 M $4.97 M
Interest Income $407,036.00 $569,319.00 $65,728.00 $427.00 $12,044.00 $1,106.00 $330.00
Interest Expense $1.58 M $1.59 M $1.30 M $1.88 M $1.46 M $142,173.00 $52,806.00
Depreciation & Amortization $209,911.00 $193,273.00 $111,529.00 $116,809.00 $201,936.00 $125,826.00 $85,376.00
EBITDA -$36.75 M -$22.14 M -$21.96 M -$2.01 M -$5.94 M -$14.57 M -$4.89 M
EBITDA Ratio 0 0 0 0 0 0 0
Operating Income Ratio 0 0 0 0 0 0 0
Total Other Income/Expenses Net -$2.29 M -$64,066.00 -$5.46 M -$1.76 M -$1.08 M -$2.95 M -$143,131.00
Income Before Tax -$39.18 M -$23.92 M -$23.37 M -$4.01 M -$7.24 M -$14.83 M -$5.00 M
Income Before Tax Ratio 0 0 0 0 0 0 0
Income Tax Expense -$89,667.00 $930,519.00 -$1.34 M $1.87 M $1.40 M -$1.46 M -$627,563.00
Net Income -$37.39 M -$23.26 M -$22.99 M -$4.00 M -$7.18 M -$13.23 M -$4.32 M
Net Income Ratio 0 0 0 0 0 0 0
EPS -1.58 -1.21 -1.61 -0.31 -0.56 -1.03 -0.34
EPS Diluted -1.58 -1.21 -1.61 -0.31 -0.56 -1.03 -0.34
Weighted Average Shares Out $24.15 M $19.29 M $14.24 M $12.87 M $12.87 M $12.87 M $12.87 M
Weighted Average Shares Out Diluted $24.15 M $19.29 M $14.24 M $12.87 M $12.87 M $12.87 M $12.87 M
Link